-
Thematic Analysis
NewCybersecurity – Thematic Intelligence
Cybersecurity Thematic Intelligence Report Overview The prospect of offensive attacks using artificial intelligence (AI) is prompting an increase in cybersecurity budgets as organizations try to understand the impact of generative AI on their security. Both start-ups and maturing cyber companies will be on the radar of larger cybersecurity companies looking for products and talent. Moreover, cybersecurity M&A will be a strong focus during 2024 as a small group of private equity players are buying up numerous cybersecurity companies. Buy the...
-
Thematic Analysis
NewEnterprise Security Software Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Artificial intelligence (AI) is a double-edged sword in cybersecurity. It can help organizations improve their threat detection, hunting, and incident response capabilities, but adversaries can and will use AI in cyberattacks. There is every likelihood that AI will spur new merger and acquisition (M&A) deals in cybersecurity, especially of companies judged to be AI specialists. In the thematic screen of GlobalData’s enterprise security software sector scorecard, AI has a weighting of 20%, higher than any other theme.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MICRO BONE MARROW TRANSPLANTS in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MICRO BONE MARROW TRANSPLANTS in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MICRO BONE MARROW TRANSPLANTS...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MICRO BONE MARROW TRANSPLANTS in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MICRO BONE MARROW TRANSPLANTS in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MICRO BONE MARROW TRANSPLANTS...
-
Sector Analysis
NewSaudi Arabia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Reasons to buy the ‘Saudi Arabia Construction’ market sizing report: Get a comprehensive analysis of the construction industry in Saudi Arabia. Access the historical and forecast valuations of the Saudi Arabian construction industry along with details of key growth drivers. Identify the sectors and sub-sectors within the Saudi Arabia construction market. Analyze the mega-project pipeline, including breakdowns by development stage across all sectors. Assess the projected spending on projects in the existing pipeline. Learn about the major projects in the Saudi...
-
Product Insights
NewContinuous Positive Airway Pressure (CPAP) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
CPAP Devices Pipeline Market Report Overview A continuous positive airway pressure machine (CPAP) is used for the treatment of sleep apnea and in intensive care units as a form of ventilation. CPAP devices provide gentle and unobstructed breathing by delivering a steady constant pressure of air through a hose that is connected to a nasal mask, nasal pillow, or a full-face mask. The CPAP devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their...
-
Product Insights
United Kingdom (UK) Professional Indemnity Insurance Market Dynamics, Trends, Opportunities and Future Market, 2024 Update
UK Professional Indemnity Insurance Market Report Overview The UK professional indemnity insurance (PII) market was worth GBP3.3 billion in 2023. With improved profitability, capacity is returning to the market, both in the form of new entrants and existing insurers which have ambitious growth targets. Premium rates are therefore now stable or declining and market growth is forecast to be much slower by 2028. However, market conditions remain very profession-specific and are affected by the size and profile of risk. Professional...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NTCELL in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTCELL in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NTCELL in Parkinson's Disease Drug Details: NTCell (Neurotrophin Cell or encapsulated choroid...
-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RP-2 in Nasopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RP-2 in Nasopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RP-2 in Nasopharyngeal Cancer Drug Details: RP-2 is under development for the...